002693 logo

Hainan Shuangcheng Pharmaceuticals Co., Ltd. Stock Price

SZSE:002693 Community·CN¥3.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002693 Share Price Performance

CN¥7.94
-0.56 (-6.59%)
CN¥7.94
-0.56 (-6.59%)
Price CN¥7.94

002693 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Imperfect balance sheet with minimal risk.

1 Risk
0 Rewards

Hainan Shuangcheng Pharmaceuticals Co., Ltd. Key Details

CN¥216.2m

Revenue

CN¥106.6m

Cost of Revenue

CN¥109.5m

Gross Profit

CN¥152.5m

Other Expenses

-CN¥43.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 29, 2026
-0.10
50.66%
-19.89%
72.0%
View Full Analysis

About 002693

Founded
2000
Employees
605
CEO
Jianming Li
WebsiteView website
www.shuangchengmed.com

Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Haikou, the People’s Republic of China.

Recent 002693 News & Updates

Recent updates

No updates